GL1X · GenesisL1 explorer

Research workbench

Crystal structure of Glyoxalase/bleomycin resistance protein/dioxygenase from Conexibacter woesei DSM 14684

Analyse Crystal structure of Glyoxalase/bleomycin resistance protein/dioxygenase from… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GYM
Type
protein
Length
283 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.56
Source
Conexibacter woesei
Molecule
Glyoxalase/bleomycin resistance protein/dioxygenase
UniProt
D3F7P7
Ligands
K, NA
Pockets
2 · best druggability 0.72

Structure

x-ray diffraction · resolution 1.56 · 2 distinct chains · 28% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlyoxalase/bleomycin resistance protein/dioxygenaseprotein13824% helix, 36% strandD3F7P7
BGlyoxalase/bleomycin resistance protein/dioxygenaseprotein14531% helix, 37% strandD3F7P7

Ligands and binding sites

  • K · Potassium ion · metal · chains A
  • NA · Sodium ion · metal · chains A
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14040.720.8353TRS
24240.660.7856empty

Interfaces

1 interface between chains.

  • A–B · 2842 Ų buried · 50 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 15 modified (engineered).

Compared structures

  • 4GYM · Crystal structure of GLYOXALASE/BLEOMYCIN resistance PROTEIN/DIOXYGENASE from… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.